Flow Cytometry in Neoplastic Hematology: Morphologic-Immunophenotypic Correlation 4/e

저 자 : Wojciech Gorczyca

 

Isbn# is : 1032055251

출판사 :

CRC Press

출판일 :

2022-12-12

ISBN10 :

1032055251

ISBN13 :

9781032055251

Edition :

4

Page :

730 Pages [ Hardcover ]

정가 :

₩300000

한국정가 :

300000 원

판매가 :

285,000원

적립금 :

0

주문수량 :

 

평점 :

 

DescriptionContentsReview
     Description
This fourth edition presents an updated and expanded text and illustrations to reflect continued morphologic, immunophenotypic, and especially molecular advances in the field of neoplastic hematology, mostly due to the rapidly expanding application of next-generation sequencing. Those advances not only allow a more reliable diagnosis of the majority of tumors and identification of early changes such as monoclonal B-cell lymphocytosis or clonal hematopoiesis of indeterminate potential (CHIP), but also in many cases identify mutations or phenotypic changes in tumors that can be targeted by mutation-specific or antigen-specific drugs.

This edition incorporates the updated WHO classification of hematopoietic tumors and new immunophenotypic and molecular markers to provide a thorough pathologic overview of hematologic neoplasms while focusing on flow cytometric features. Special emphasis has been put on hematological neoplasms with crucial clinical significance such as acute promyelocytic leukemia, other acute leukemias, and difficult areas in flow cytometry. Flow cytometric features in AML, MDS, CMML, CLL and measurable residual disease were significantly expanded. There are many new comparative tables, illustrations, and diagrams of algorithmic approaches.
     Contents
     독자서평
※서평을 쓰시면 관리자 확인 후 일정 포인트(1,000포인트이상)의 적립금을 적립해 드립니다.


 

 

 

 

회사소개  |  FAQ  |  물어보기  |  ID,PWD찾기  |  E-mail  |  Foreigner  |  개인정보 취급방침  |  출판의뢰  |  대량주문
▲Top  
매장주소: 서울시 강서구 공항대로168 마곡747타워 1303호(지하철5호선 마곡역 6번출구)

전화: 02-763-9188 | 팩스: 02-763-5490 |

HP: 010-3750-5497 | 대표: 주필체 | 사업자: 130-90-16309 [통신판매]제 01-3604호 
Copyright 2001 by 바이오메디북(Biomedbook) All right reserved.